Clinical trial
Biospecimen Collection for:Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases
NCT04682665 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biospecimen Collection for:Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases
- Lead sponsor
- University of Leeds
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 16, 2021
- Completion date
- July 31, 2024
- Enrollment
- 81 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer liver metastasis